In 2023, the Insulin in Dosage Market Size Value Per Capita in South Africa stood at 3.11 USD. From 2024 onwards, the market is forecasted to experience a slight yearly decline. Specifically, from 2024 to 2025, the value drops by -0.97%, followed by a -0.65% decrease from 2025 to 2026, a -0.66% decline from 2026 to 2027, and a -0.66% fall from 2027 to 2028. Over the five years (2024-2028), the compound annual growth rate (CAGR) is estimated at -0.72%.
Future trends to watch for include technological advancements in insulin delivery methods, increasing prevalence of diabetes, changes in healthcare policies, and potential economic factors that may affect the affordability and accessibility of insulin for the population of South Africa.
